HN2011001184A - Forma de dosificacion oral de liberacion prolongada de acetaminofeno/tramadol - Google Patents
Forma de dosificacion oral de liberacion prolongada de acetaminofeno/tramadolInfo
- Publication number
- HN2011001184A HN2011001184A HN2011001184A HN2011001184A HN2011001184A HN 2011001184 A HN2011001184 A HN 2011001184A HN 2011001184 A HN2011001184 A HN 2011001184A HN 2011001184 A HN2011001184 A HN 2011001184A HN 2011001184 A HN2011001184 A HN 2011001184A
- Authority
- HN
- Honduras
- Prior art keywords
- tramadol
- dosage form
- acetaminofen
- prolonged
- oral dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
LA PRESENTE INVENCION DESCRIBE UNA FORMA DE DOSIFICACION DE LIBERACION PROLONGADA DE ADMINISTRACION ORAL DE ACETAMINOFENO Y TRAMADOL. LA FORMA DE DOSIFICACION INCLUYE UNA COMPOSICION DE ACETAMINOFENO JUNTO CON UN COMPLEJO DE TRAMADOL FORMADO CON UN POIMERO ANIONICO. EL COMPLEJO DE TRAMADOL PROPORCIONA LA LIBERACION SOSTENIDA DE TRAMADOL PARA UN PERFIL DE LIBERACION SINCRONIZADO (COORDINADO) DE ACETAMINOFENO Y TRAMADOL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10861808P | 2008-10-27 | 2008-10-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2011001184A true HN2011001184A (es) | 2014-09-01 |
Family
ID=41514164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2011001184A HN2011001184A (es) | 2008-10-27 | 2011-04-27 | Forma de dosificacion oral de liberacion prolongada de acetaminofeno/tramadol |
Country Status (26)
Country | Link |
---|---|
US (1) | US20100104638A1 (es) |
EP (1) | EP2362768B1 (es) |
JP (1) | JP5713911B2 (es) |
KR (3) | KR20110119845A (es) |
CN (2) | CN102264355A (es) |
AU (1) | AU2009320181B2 (es) |
BR (1) | BRPI0920082A2 (es) |
CA (1) | CA2741751C (es) |
CL (1) | CL2011000935A1 (es) |
CO (1) | CO6331423A2 (es) |
CR (1) | CR20110287A (es) |
EA (1) | EA023149B1 (es) |
EC (1) | ECSP11011009A (es) |
ES (1) | ES2582779T3 (es) |
HK (1) | HK1162915A1 (es) |
HN (1) | HN2011001184A (es) |
IL (1) | IL212453A (es) |
MX (1) | MX339867B (es) |
MY (1) | MY161550A (es) |
NI (1) | NI201100079A (es) |
NZ (1) | NZ592325A (es) |
PE (1) | PE20110855A1 (es) |
TW (1) | TWI561257B (es) |
UA (1) | UA102706C2 (es) |
WO (1) | WO2010062524A1 (es) |
ZA (1) | ZA201103880B (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE10361596A1 (de) * | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) * | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
BRPI0906467C1 (pt) | 2008-01-25 | 2021-05-25 | Gruenenthal Gmbh | forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada |
LT2273983T (lt) | 2008-05-09 | 2016-10-25 | Grünenthal GmbH | Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija |
AU2010275754B2 (en) * | 2009-07-22 | 2014-05-15 | Grünenthal GmbH | Tamper-resistant dosage form for oxidation-sensitive opioids |
EP2456427B1 (en) | 2009-07-22 | 2015-03-04 | Grünenthal GmbH | Hot-melt extruded controlled release dosage form |
WO2012028319A1 (en) | 2010-09-02 | 2012-03-08 | Grünenthal GmbH | Tamper resistant dosage form comprising inorganic salt |
MX2013002293A (es) | 2010-09-02 | 2013-05-09 | Gruenenthal Gmbh | Forma de dosificacion resistente a alteracion que comprende un polimero anionico. |
SG194605A1 (en) * | 2011-05-06 | 2013-12-30 | Glaxosmithkline Llc | Sustained release paracetamol formulations |
US10702485B2 (en) | 2011-07-09 | 2020-07-07 | Syntrix Biosystems Inc. | Compositions and methods for overcoming resistance to tramadol |
LT2736497T (lt) | 2011-07-29 | 2017-11-10 | Grünenthal GmbH | Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu |
BR112014002022A2 (pt) | 2011-07-29 | 2017-02-21 | Gruenenthal Gmbh | comprimido resistente à violação proporcionando liberação de fármaco imediata |
US20130225697A1 (en) | 2012-02-28 | 2013-08-29 | Grunenthal Gmbh | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
AU2013248351B2 (en) | 2012-04-18 | 2018-04-26 | Grunenthal Gmbh | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
EP2846812A2 (en) * | 2012-05-10 | 2015-03-18 | FMC Corporation | Controlled release solid dose form |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
CA2907950A1 (en) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Tamper-resistant dosage form containing one or more particles |
JP6466417B2 (ja) | 2013-05-29 | 2019-02-06 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形 |
DE102013009114A1 (de) | 2013-05-29 | 2014-12-04 | Franz Gerstheimer | Pharmazeutische Zusammensetzung zur Überwindung von Metabolisierungsproblemen |
EA032465B1 (ru) | 2013-07-12 | 2019-05-31 | Грюненталь Гмбх | Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления |
IN2013MU03098A (es) * | 2013-09-30 | 2015-07-17 | Athena Drug Delivery Solutions Pvt Ltd | |
AU2014356581C1 (en) | 2013-11-26 | 2020-05-28 | Grunenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
CA2931547A1 (en) | 2013-12-09 | 2015-06-18 | Durect Corporation | Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same |
MX2016007848A (es) | 2013-12-16 | 2016-09-07 | Gruenenthal Gmbh | Forma de dosificacion resistente a alteraciones con perfil de liberacion bimodal fabricado mediante co-extrusion. |
CN106572980A (zh) | 2014-05-12 | 2017-04-19 | 格吕伦塔尔有限公司 | 包含他喷他多的防篡改即释胶囊制剂 |
CN106456550A (zh) | 2014-05-26 | 2017-02-22 | 格吕伦塔尔有限公司 | 避免乙醇剂量倾泻的多颗粒 |
AU2016251854A1 (en) | 2015-04-24 | 2017-10-19 | Grunenthal Gmbh | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
ES2913642T3 (es) * | 2017-10-13 | 2022-06-03 | Altus Formulation Inc | Excipientes modificadores de la liberación a base de almidón y composiciones farmacéuticas derivadas de los mismos |
GB2567493B (en) | 2017-10-13 | 2019-12-18 | Altus Formulation Inc | Starch-based release modifying excipients and pharmaceutical compositions derived therefrom |
US11000488B2 (en) | 2019-03-22 | 2021-05-11 | Syntrix Biosystems Inc. | Treating pain using desmetramadol |
KR20240027436A (ko) * | 2022-08-23 | 2024-03-04 | 대원제약주식회사 | 펠루비프로펜 및 트라마돌의 이온결합 화합물, 이를 포함하는 조성물, 및 이의 제조 방법 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58206751A (ja) * | 1982-05-26 | 1983-12-02 | 日石三菱株式会社 | 創傷被覆材 |
AU651247B2 (en) | 1991-09-06 | 1994-07-14 | Mcneilab, Inc. | Composition comprising a tramadol material and acetaminophen and its use |
CA2173818A1 (fr) * | 1996-04-10 | 1997-10-11 | Francois Chouinard | Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose |
US6375957B1 (en) * | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
EP1555022B1 (en) | 2002-09-21 | 2008-02-20 | Shuyi Zhang | Sustained release formulation of acetaminophen and tramadol |
RU2328275C2 (ru) * | 2002-10-25 | 2008-07-10 | Лабофарм Инк. | Композиции трамадола пролонгированного высвобождения с 24-часовым действием |
US20080176873A1 (en) * | 2004-11-10 | 2008-07-24 | Trinity Laboratories, Inc. | Novel Pharmaceutical Compositions for Treating Acquired Chronic Pain and Associated Dysphoria |
EP1917000A2 (en) * | 2005-07-07 | 2008-05-07 | Farnam Companies, Inc. | Sustained release pharmaceutical compositions for highly water soluble drugs |
PL1931346T3 (pl) * | 2005-09-09 | 2013-01-31 | Angelini Labopharm Llc | Kompozycja trazodonu do podawania raz na dobę |
CN1785167A (zh) * | 2005-10-08 | 2006-06-14 | 王鸣 | 一种非麻醉性镇痛剂的复方缓释制剂的制备方法 |
DE102006056458A1 (de) * | 2006-11-28 | 2008-05-29 | Grünenthal GmbH | Arzneimittelzubereitung von Tramadol und Acetaminophen |
MY153971A (en) * | 2007-07-18 | 2015-04-30 | Janssen Pharmaceutica Nv | Sulfonamides as trpm8 modulators |
AU2008338207A1 (en) * | 2007-12-17 | 2009-06-25 | Labopharm (Barbados) Limited | Misuse preventative, controlled release formulation |
AU2009223061B2 (en) * | 2008-03-11 | 2014-10-09 | Depomed Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
-
2009
- 2009-10-23 KR KR1020117024463A patent/KR20110119845A/ko active Application Filing
- 2009-10-23 EA EA201170616A patent/EA023149B1/ru not_active IP Right Cessation
- 2009-10-23 KR KR1020137031476A patent/KR101631140B1/ko active IP Right Grant
- 2009-10-23 AU AU2009320181A patent/AU2009320181B2/en not_active Ceased
- 2009-10-23 US US12/604,560 patent/US20100104638A1/en not_active Abandoned
- 2009-10-23 ES ES09740619.3T patent/ES2582779T3/es active Active
- 2009-10-23 BR BRPI0920082A patent/BRPI0920082A2/pt not_active IP Right Cessation
- 2009-10-23 MY MYPI2011001827A patent/MY161550A/en unknown
- 2009-10-23 MX MX2011004403A patent/MX339867B/es active IP Right Grant
- 2009-10-23 PE PE2011000940A patent/PE20110855A1/es not_active Application Discontinuation
- 2009-10-23 JP JP2011534641A patent/JP5713911B2/ja not_active Expired - Fee Related
- 2009-10-23 KR KR1020117004791A patent/KR20110036858A/ko active Application Filing
- 2009-10-23 CA CA2741751A patent/CA2741751C/en not_active Expired - Fee Related
- 2009-10-23 EP EP09740619.3A patent/EP2362768B1/en active Active
- 2009-10-23 UA UAA201106620A patent/UA102706C2/ru unknown
- 2009-10-23 NZ NZ592325A patent/NZ592325A/xx not_active IP Right Cessation
- 2009-10-23 CN CN2009801536507A patent/CN102264355A/zh active Pending
- 2009-10-23 CN CN201610873739.2A patent/CN107028908A/zh active Pending
- 2009-10-23 WO PCT/US2009/061803 patent/WO2010062524A1/en active Application Filing
- 2009-10-26 TW TW098136097A patent/TWI561257B/zh not_active IP Right Cessation
-
2011
- 2011-04-26 CL CL2011000935A patent/CL2011000935A1/es unknown
- 2011-04-26 CO CO11050889A patent/CO6331423A2/es not_active Application Discontinuation
- 2011-04-26 IL IL212453A patent/IL212453A/en not_active IP Right Cessation
- 2011-04-27 EC EC2011011009A patent/ECSP11011009A/es unknown
- 2011-04-27 HN HN2011001184A patent/HN2011001184A/es unknown
- 2011-04-27 NI NI201100079A patent/NI201100079A/es unknown
- 2011-05-26 ZA ZA2011/03880A patent/ZA201103880B/en unknown
- 2011-05-27 CR CR20110287A patent/CR20110287A/es unknown
-
2012
- 2012-03-06 HK HK12102269.6A patent/HK1162915A1/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HN2011001184A (es) | Forma de dosificacion oral de liberacion prolongada de acetaminofeno/tramadol | |
BR112013019223A2 (pt) | forma de dosagem para liberação modificada, processo para a fabricação de um comprimido e processo para a fabricação de uma forma de dosagem oral | |
CR11740A (es) | Composiciones que comprenden fármacos levemente básicos y formas de dosificación de liberación controlada | |
CL2013003145A1 (es) | Formulación farmacéutica que comprende mezcla de anticuerpo anti-alfa4beta7, un antioxidante o quelante y al menos un aminoácido libre. | |
MY194495A (en) | Compositions and methods for transmucosal absorption | |
BRPI0714539B8 (pt) | processo para obtenção de forma de dosagem farmaceutica de liberação prolongada de opioides | |
CR8929A (es) | Polimorfo ii de rapamicina y usos del mismo | |
BRPI0509184A (pt) | composições farmacêuticas | |
WO2010102252A9 (en) | Oral dosage forms having a high loading of a gabapentin prodrug | |
CR20120008A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
GT201200284A (es) | Composición farmacéutica | |
AR088232A1 (es) | Composiciones farmaceuticas | |
ATE530170T1 (de) | Paliperidonformulierung mit verzögerter freisetzung | |
AR092356A1 (es) | Formulacion compuesta para administracion oral que comprende metformina y rosuvastatina y metodo de preparacion de la formulacion | |
CY1113641T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει aleglitazar | |
GT201400042A (es) | Compuesto de benzotiazolona | |
GT201500038A (es) | Composicion de difenidol de liberacion prolongada. | |
DOP2013000258A (es) | Formulaciones de liberación sostenida de paracetamol | |
ECSP13012459A (es) | Valsartan altamente cristalino | |
UY33772A (es) | Composición farmacéutica que comprende clorhidrato de lercanidipina y valsartán como componentes activos y a un método para la preparacion de la misma. | |
CR9329S (es) | Troquel o dado para dar forma | |
AR067351A1 (es) | Combinacion de picotamida con nafronil | |
IT1396316B1 (it) | Proiettore ad ampia diffusione con sorgenti leds precollimate. | |
AR059327A1 (es) | Monohidrato de rimonabant su procedimiento de preparacion y composiciones farmaceuticas que lo contienen | |
CR20130288A (es) | Comprimido farmacéutico de liberación controlada para administración oral |